Helga Radner

Summary

Affiliation: Medical University of Vienna
Country: Austria

Publications

  1. doi request reprint Physical function continues to improve when clinical remission is sustained in rheumatoid arthritis patients
    Helga Radner
    Department of Internal Medicine III, Division of Rheumatology, Medical University Vienna, Waehringer Guertel 18 20, A 1090, Vienna, Austria
    Arthritis Res Ther 17:203. 2015
  2. doi request reprint Anti-TNF in rheumatoid arthritis: an overview
    Helga Radner
    Department of Internal Medicine III, Division of Rheumatology, Medical University Vienna, Waehringer Guertel 18 20, 1090, Vienna, Austria
    Wien Med Wochenschr 165:3-9. 2015
  3. pmc Value of self-performed joint counts in rheumatoid arthritis patients near remission
    Helga Radner
    Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Waehringerguertel 18 20, Vienna, 1090, Austria
    Arthritis Res Ther 14:R61. 2012
  4. doi request reprint How do gastrointestinal or liver comorbidities influence the choice of pain treatment in inflammatory arthritis? A Cochrane systematic review
    Helga Radner
    Department of Rheumatology, Medical University Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    J Rheumatol Suppl 90:74-80. 2012
  5. doi request reprint Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis
    Helga Radner
    Department of Internal Medicine 3, Medical University Vienna, 1090 Vienna, Austria
    Rheumatology (Oxford) 50:381-8. 2011
  6. doi request reprint Impact of comorbidity on physical function in patients with rheumatoid arthritis
    Helga Radner
    Division of Rheumatology, Department of Internal Medicine 3, Medical University Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Ann Rheum Dis 69:536-41. 2010
  7. doi request reprint The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs
    Helga Radner
    Division of Rheumatology, Immunology and Allergy, Brigham and Women s Hospital, Boston, MA, USA, Department of Internal Medicine III, Division of Rheumatology, Medical University Vienna, Vienna, Austria and
    Rheumatology (Oxford) 54:2076-84. 2015
  8. doi request reprint Sonographic joint assessment in rheumatoid arthritis: associations with clinical joint assessment during a state of remission
    Miriam Gärtner
    Medical University of Vienna, Vienna, Austria
    Arthritis Rheum 65:2005-14. 2013
  9. doi request reprint Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondylarthritis) and gastrointestinal or liver comorbidity
    Helga Radner
    Division of Rheumatology, Department of InternalMedicine 3, MedicalUniversityVienna, Vienna
    Cochrane Database Syst Rev 1:CD008951. 2012
  10. doi request reprint Immunodominant T-cell epitopes of hnRNP-A2 associated with disease activity in patients with rheumatoid arthritis
    Sylvie Trembleau
    Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
    Eur J Immunol 40:1795-808. 2010

Detail Information

Publications17

  1. doi request reprint Physical function continues to improve when clinical remission is sustained in rheumatoid arthritis patients
    Helga Radner
    Department of Internal Medicine III, Division of Rheumatology, Medical University Vienna, Waehringer Guertel 18 20, A 1090, Vienna, Austria
    Arthritis Res Ther 17:203. 2015
    ..To investigate the course of functional status assessed by health assessment questionnaire (HAQ) in rheumatoid arthritis (RA) patients with sustained clinical remission (REM)...
  2. doi request reprint Anti-TNF in rheumatoid arthritis: an overview
    Helga Radner
    Department of Internal Medicine III, Division of Rheumatology, Medical University Vienna, Waehringer Guertel 18 20, 1090, Vienna, Austria
    Wien Med Wochenschr 165:3-9. 2015
    ..However, only little is known if "biologic free" remission is possible in patients with sustained remission following intensive TNF-α inhibitor therapy. ..
  3. pmc Value of self-performed joint counts in rheumatoid arthritis patients near remission
    Helga Radner
    Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Waehringerguertel 18 20, Vienna, 1090, Austria
    Arthritis Res Ther 14:R61. 2012
    ..To determine the validity and reliability of patients' self-performed joint counts compared to joint counts by professional assessors in rheumatoid arthritis (RA) patients in different disease activity states...
  4. doi request reprint How do gastrointestinal or liver comorbidities influence the choice of pain treatment in inflammatory arthritis? A Cochrane systematic review
    Helga Radner
    Department of Rheumatology, Medical University Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    J Rheumatol Suppl 90:74-80. 2012
    ..To assess efficacy and safety of pharmacological pain treatment in patients with inflammatory arthritis (IA) and gastrointestinal (GI) or liver comorbidities...
  5. doi request reprint Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis
    Helga Radner
    Department of Internal Medicine 3, Medical University Vienna, 1090 Vienna, Austria
    Rheumatology (Oxford) 50:381-8. 2011
    ..In this study, we investigated the impact of comorbidities on individual activities of daily living, and other aspects of quality of live in patients with RA...
  6. doi request reprint Impact of comorbidity on physical function in patients with rheumatoid arthritis
    Helga Radner
    Division of Rheumatology, Department of Internal Medicine 3, Medical University Vienna, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Ann Rheum Dis 69:536-41. 2010
    ..Physical disability is a main outcome in rheumatoid arthritis (RA) which tends to increase with comorbidities. However, the extent to which comorbidities contribute to the multifactorial process of disability has not been investigated...
  7. doi request reprint The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs
    Helga Radner
    Division of Rheumatology, Immunology and Allergy, Brigham and Women s Hospital, Boston, MA, USA, Department of Internal Medicine III, Division of Rheumatology, Medical University Vienna, Vienna, Austria and
    Rheumatology (Oxford) 54:2076-84. 2015
    ..When treating RA patients, remission (REM) or at least low disease activity (LDA) is the ultimate therapeutic goal. The aim of this study was to assess the impact of multimorbidity on achieving REM or LDA...
  8. doi request reprint Sonographic joint assessment in rheumatoid arthritis: associations with clinical joint assessment during a state of remission
    Miriam Gärtner
    Medical University of Vienna, Vienna, Austria
    Arthritis Rheum 65:2005-14. 2013
    ..e., an active joint) is defined. The present study was undertaken to compare clinically active joints with sonographically active joints in patients with RA, applying different sonographic definitions of an active joint...
  9. doi request reprint Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondylarthritis) and gastrointestinal or liver comorbidity
    Helga Radner
    Division of Rheumatology, Department of InternalMedicine 3, MedicalUniversityVienna, Vienna
    Cochrane Database Syst Rev 1:CD008951. 2012
    ..Because comorbidity is highly prevalent in people with inflammatory arthritis, it is important to consider comorbidities such as gastrointestinal or liver diseases in deciding upon optimal pharmacologic pain therapy...
  10. doi request reprint Immunodominant T-cell epitopes of hnRNP-A2 associated with disease activity in patients with rheumatoid arthritis
    Sylvie Trembleau
    Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
    Eur J Immunol 40:1795-808. 2010
    ..These data suggest involvement of hnRNP-A2 specific cellular autoimmune responses in RA pathogenesis...
  11. doi request reprint Development of a multimorbidity index: Impact on quality of life using a rheumatoid arthritis cohort
    Helga Radner
    Division of Rheumatology, Immunology and Allergy, Brigham and Women s Hospital, 75 Francis St, Boston MA, 02115 Division of Rheumatology, Department of Internal Medicine III, Medical University Vienna, Vienna, Austria Electronic address
    Semin Arthritis Rheum 45:167-73. 2015
    ..To develop a multimorbidity index (MMI) based on health-related quality of life (HRQol)...
  12. doi request reprint Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review
    Helga Radner
    Department of Medicine III, Division of Rheumatology, Medical University Vienna, Vienna, Austria
    Ann Rheum Dis 73:114-23. 2014
    ..The 2010 ACR/EULAR classification criteria for rheumatoid arthritis (RA) were developed to improve the identification of individuals for studies of RA. We aimed to summarise the performance of the criteria based on the published literature...
  13. doi request reprint Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity
    Paul Studenic
    Medical University of Vienna, Vienna, Austria
    Arthritis Rheum 64:2814-23. 2012
    ..The purpose of this study was to explore the extent and reasons for this discordance...
  14. doi request reprint Serological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritis
    Christoph Böhler
    Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Waehringer Guertel 18 20, Vienna 1090, Austria
    Ann Rheum Dis 72:241-4. 2013
    ..To investigate changes of rheumatoid factor (RF) and antibodies against citrullinated peptides (ACPA) during therapy with disease modifying antirheumatic drugs...
  15. doi request reprint Treatment Patterns of Multimorbid Patients with Rheumatoid Arthritis: Results from an International Cross-sectional Study
    Helga Radner
    From the Division of Rheumatology, Immunology and Allergy, Brigham and Women s Hospital, and Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA Department of Internal Medicine III, Division of Rheumatology, Medical University Vienna, Vienna, Austria Mohammed V Souissi University, Faculty of Medicine, Laboratory of Biostatistics, Clinical Research and Epidemiology LBRCE, Rabat, Morocco Paris Descartes University, Department of Rheumatology Hôpital Cochin, Assistance Publique Hopitaux de Paris, EULAR center of excellence, INSERM U1153 Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris Cité, Paris, France H Radner, MD, Division of Rheumatology, Immunology and Allergy, Brigham and Women s Hospital, and Department of Internal Medicine III, Division of Rheumatology, Medical University Vienna K Yoshida, MD, MPH, Department of Epidemiology, Harvard School of Public Health I Hmamouchi, MD, PhD, Mohammed V Souissi University, Faculty of Medicine, Laboratory of Biostatistics, LBRCE M Dougados, MD
    J Rheumatol 42:1099-104. 2015
    ..To describe the treatment profile of multimorbid patients with rheumatoid arthritis (RA) in contrast to patients with RA only...
  16. doi request reprint Incidence and Predictors of Biological Antirheumatic Drug Discontinuation Attempts among Patients with Rheumatoid Arthritis in Remission: A CORRONA and NinJa Collaborative Cohort Study
    Kazuki Yoshida
    From the Division of Rheumatology, Immunology and Allergy, Brigham and Women s Hospital Department of Epidemiology, Harvard T H Chan School of Public Health, Boston University of Massachusetts Medical School, Worcester, Massachusetts New York University Hospital for Joint Diseases, New York Albany Medical College, Center for Rheumatology, Albany, New York Division of Rheumatology, Allergy and Immunology, University of California San Diego, La Jolla, California, USA Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway Immuno Rheumatology Center, St Luke s International Hospital, Tokyo Department of Rheumatology, Kameda Medical Center, Kamogawa Department of Clinical Research, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka Department of Rheumatology, Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan K Yoshida, MD, MPH, Division of Rheumatology, Immunology and Allergy, Brigham and Women s Hospital, and Department of Epidemiology, Germany
    J Rheumatol 42:2238-46. 2015
    ....